Pentraxin 3 and epicardial fat thickness are independently associated with diabetic retinopathy in diabetic patients
- 29 Downloads
Previous studies have shown that diabetic retinopathy and inflammation are closely related. Pentraxin 3 (PTX3), high-sensitive C-reactive protein (HsCRP), and epicardial fat thickness (EFT) are parameters associated with inflammation. The aim of this cross-sectional study, was to determine if the levels of HsCRP, PTX3, and EFT were predictors or markers for diabetic retinopathy (DR). Cross-sectional study, 40 normal, nondiabetic subjects (group1), 50 type 2 diabetic patients without DR (group2), and 110 type 2 diabetic patients with DR (group3) were included. PTX3 and HsCRP concentrations were measured and transthoracic echocardiography was used to measure EFT. ANOVA and the post hoc multiple comparisons showed that differences among group 1 and group 2 and also among group 2 and group 3 for PTX3 (p < 0.01 and p = 0.018, respectively), for HsCRP (p < 0.01 and p = 0.042, respectively), and for EFT (p < 0.01 and p = 0.021, respectively) were statistically significant. The difference in serum creatinine was statistically significant only among group 2 and group 3 (p < 0.01). Diabetes duration (OR = 1.116, p < 0.01), PTX3 (OR = 8.516, p = 0.039), EFT (OR = 1.444, p = 0.02), and serum creatinine level (OR = 15.45, p = 0.015) have independent association with DR. Besides, the well-known factors such as diabetes duration and serum creatinine, PTX3, as a marker of inflammation, and EFT, as a marker of inflammation and vascular damage, were independently associated with DR in diabetic patients. Clinical trial number: 20.03.2015/30
KeywordsDiabetic retinopathy Pentraxin 3 HsCRP Epicardial fat tissue
This study was funded by the Scientific Research Projects of the University of Bozok.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Bozok University Clinical Research Ethics Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 2.Mallika P, Lee P, Cheah W, Wong J, Syed Alwi S, Nor Hayati H, et al. Risk factors for diabetic retinopathy in diabetics screened using fundus photography at a primary health care setting in East Malaysia. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia. 2011;6(2–3):60–5.Google Scholar
- 6.Wang X, Dai Y, Chen X. Changes of the concentration of serum adiponectin and high sensitivity C-reactive protein in type 2 diabetes mellitus patients with retinopathy. International Journal of Ophthalmology. 2010;10:1699–701.Google Scholar
- 10.Saygi S, Kirilmaz B, Tengiz I, Turk UO, Yildiz H, Tuzun N, et al. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2012;40(3):205–12. https://doi.org/10.5543/tkda.2012.90083.CrossRefGoogle Scholar
- 12.Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation. 2004;110(16):2349–54. https://doi.org/10.1161/01.cir.0000145167.30987.2e.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G (2006) Long pentraxin 3: a marker of inflammation in untreated psoriatic patients. Int J Mol Med 18 (3):415–423.Google Scholar
- 14.Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol. 2007;27(1):161–7. https://doi.org/10.1161/01.ATV.0000252126.48375.d5.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Suzuki S, Takeishi Y, Niizeki T, Koyama Y, Kitahara T, Sasaki T, et al. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Am Heart J. 2008;155(1):75–81. https://doi.org/10.1016/j.ahj.2007.08.013.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, et al. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol. 2011;57(7):861–9. https://doi.org/10.1016/j.jacc.2010.10.018.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Balta S, Demirkol S, Kurt O, Sarlak H, Akhan M. Epicardial adipose tissue measurement: inexpensive, easy accessible and rapid practical method. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology. 2013;13(6):611. https://doi.org/10.5152/akd.2013.207.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–8. https://doi.org/10.1210/jc.2003-030698.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011;214(1):3–10. https://doi.org/10.1016/j.atherosclerosis.2010.05.034.CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–6. https://doi.org/10.1161/01.cir.0000099542.57313.c5.CrossRefGoogle Scholar
- 35.Stram DA, Jiang X, Varma R, Torres M, Burkemper BS, Choudhury F, et al. Factors associated with prevalent diabetic retinopathy in Chinese Americans: the Chinese American Eye Study. Ophthalmology retina. 2018;2(2):96–105. https://doi.org/10.1016/j.oret.2017.05.014.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Tokgözoğlu L. Ateroskleroz ve enflamasyonun rolü. Türk Kardiyol Dern Arş. 2009;4:1–6.Google Scholar